Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cormedix Inc. logo — company profile

Cormedix Inc.

Founded 2006 United States United States 93 employees Post Ipo Equity Biotechnology, Health Care

General Information

Company Name Cormedix Inc.
Founded Year 2006
Location United States United States +1
Employees 93
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Cormedix Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cormedix Inc.

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company is focused on developing its lead product DefenCath™, a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product (QIDP), and the original New Drug Application (NDA) received priority review in recognition of its potential to address an unmet medical need. For more information, visit: www.cormedix.com.

No funding data available for Cormedix Inc. yet.

Get notified when Cormedix Inc. raises funding

Cormedix Inc. Alternatives & Competitors

Cormedix Inc. vs
Zalgen
Zalgen United States

Global Innovations. Solutions for all.

9 employees
Biotechnology, Health Care
Compare Cormedix Inc. vs Zalgen
Cormedix Inc. vs
Tetralogic Pharmaceuticals
Tetralogic Pharmaceuticals

TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on d...

Convertible Note
10 employees
Biotechnology, Health Care
Compare Cormedix Inc. vs Tetralogic Pharmaceuticals
Cormedix Inc. vs
Medarex
Medarex United States

Medarex is a biopharmaceutical company focused on the discovery, development, and potential commerci...

93 employees
Biotechnology
Also compare with: Cormedix Inc. vs AN2 Therapeutics AN2 Therapeutics

FAQ About Cormedix Inc.

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company is focused on developing its lead product DefenCath™, a novel, antibacterial and antifungal solution des...
Cormedix Inc. was founded in 2006.
Cormedix Inc. is headquartered in United States.
Cormedix Inc. operates in the following industries: Biotechnology, Health Care.
Cormedix Inc. has approximately 93 employees.
Top alternatives and competitors to Cormedix Inc. include Zalgen, Tetralogic Pharmaceuticals, Medarex, Aviragen Therapeutics, Nanopharmaceutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cormedix Inc. and Zalgen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cormedix Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes